ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 660027 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 660027; 2) Community: the network communities that were significantly associated with the response to NSC 660027; 3) Molecule: the relationships between components within communities and NSC 660027; 4) MDR: the compounds that were significantly associated with the NSC 660027.

NSC Compound Enrichment Correlation
NSC 269720 Androstan-17-one, 3-[[[(2-chloroethyl)nitrosoamino]carbonyl]oxy]-, (3.alpha.,5.alpha.)- 0.0385613993886001 0.42863135
NSC 355457 11H-Indeno[1,2-c]isoquinolinium, 9-hydroxy-2,3,8-trimethoxy-6-methyl-, chloride 0.0385613993886001 0.50853332
NSC 45236 Null 0.0385613993886001 0.40444773
NSC 602617 Benzo[g]quinoxaline-5,10-dione, 5,10-dihydro-2,3-dimethyl- 0.0385613993886001 0.0030570282
NSC 606497 Camptothecin Derivative 0.0385613993886001 0.56168699
NSC 606499 Camptothecin Derivative 0.0385613993886001 0.53316485
NSC 629229 Null 0.0385613993886001 0.036135727
NSC 642324 Null 0.0385613993886001 0.7251709
NSC 649904 Cyclopentanone, 5-[(4-morpholinyl)methyl]-2-pentylidene-, hydrochloride 0.0385613993886001 0.17233129
NSC 658257 Naphthalen-2-one, 4-[(4-bromophenyl)amino]-1,2-dihydro-1-(hydroxyimino)- 0.0385613993886001 0.033018187
Total:52  Current:35    [First] [Prev] [Next] [Last]